EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Majoon Sarakhs: A polyherbal Unani formulation with total phenolics, flavonoids, in vitro antioxidant activity, and in silico molecular modeling insights for drug discovery

Huda Nafees, Sana Nafees, Imran Khan, Mohamed L. Ashour, Fadia S. Youssef

Letters in Drug Design & Discovery · 2026-09 · 23 (9) · 100638

DOI: 10.1016/j.lddd.2026.100638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-09. Verfasst von Huda Nafees und 4 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Majoon Sarakhs is a Unani polyherbal pharmacopoeia formulation used as an anthelmintic. Pronounced health-promoting potential was observed when various herbal drugs are combined hence this research aimed to consolidate the implementation of Majoon Sarakhs as a natural antioxidant.

Methods

Total phenols and flavonoids present in Majoon Sarakhs extract were determined by Folin–Ciocalteu reagent and aluminum chloride, respectively. Markers identification was performed in the extract using HPLC. The antioxidant potential was assessed in vitro by Potassium ferricyanide–trichloroacetic acid–ferric chloride reducing power assay (Oyaizu’s method) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging capacity methods. In silico study was done on secondary metabolites of its natural ingredients versus myeloperoxidase NADPH oxidase. Molecular dynamics, ADME/TOPKAT prediction and drug-likeness were done to further ascertain the in vitro experiments.

Results

Total phenols and flavonoids were 13.55 µg GAE and 11.472 µg QE equivalents/mL of the tested sample respectively. Majoon Sarakhs displayed antioxidant potential with IC50 of 212 µg/mL in the DPPH assay. Docking studies showed that embelin showed the highest fitting inside the binding centers of NADPH oxidase and myeloperoxidase oxidase, with C-Docker energies of -37.08 and -28.45 kcal/mol, respectively that was further confirmed by molecular dynamics. ADME/TOPKAT prediction reasonable pharmacodynamic, pharmacokinetic, toxicity, and drug properties for some of the tested compounds whereas unfavorable findings were detected for others.

Conclusion

Incorporation of Majoon Sarakhs , in pharmaceutical products may combat oxidative stress by serving as antioxidant as revealed from preliminary antioxidant activity in cell-free assays whereas additional in vivo , preclinical and safety studies for the whole herbal formulation are recommended.

Zitieren

APA

Nafees, H., Nafees, S., Khan, I., Ashour, M. L., & Youssef, F. S. (2026). Majoon Sarakhs: A polyherbal Unani formulation with total phenolics, flavonoids, in vitro antioxidant activity, and in silico molecular modeling insights for drug discovery. Letters in Drug Design & Discovery, 23(9), 100638. https://doi.org/10.1016/j.lddd.2026.100638

Vancouver

Nafees H, Nafees S, Khan I, Ashour ML, Youssef FS. Majoon Sarakhs: A polyherbal Unani formulation with total phenolics, flavonoids, in vitro antioxidant activity, and in silico molecular modeling insights for drug discovery. Letters in Drug Design & Discovery. 2026;23(9):100638. doi:10.1016/j.lddd.2026.100638

BibTeX
@article{Nafees2026,
  author = {Nafees, Huda and Nafees, Sana and Khan, Imran and Ashour, Mohamed L. and Youssef, Fadia S.},
  title = {Majoon Sarakhs: A polyherbal Unani formulation with total phenolics, flavonoids, in vitro antioxidant activity, and in silico molecular modeling insights for drug discovery},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  volume = {23},
  number = {9},
  pages = {100638},
  doi = {10.1016/j.lddd.2026.100638}
}
Kostenlos starten →